Table II.
Preparation of PDMS/IMC Nanoparticles: Experimental Details and DLS Results
| NP code | Blend code | Cross-linking reagents | Surfactant | Nanoparticle yield, %a | Drug load, %b | Z ave (nm) | PDI |
|---|---|---|---|---|---|---|---|
| A | 1 | – | S1 | 100 | 19.9 ± 0.1 | 252 | 0.413 |
| B | 1 | TEOS, DBTDL | S1 | 93 | 17.5 ± 0.3 | 214 | 0.432 |
| C | 3 | TEOS | S1 | 88 | 45.2 ± 0.3 | 246 | 0.422 |
| D | 4 | TEOS, DBTDL | S1 | 81 | 55.6 ± 0.2 | 165 | 0.240 |
| E | 1 | – | S2 | 100 | 20 ± 0.1 | 298 | 0,443 |
| F | 2 | – | S2 | 89 | 39.7 ± 0.2 | 485 | 0.534 |
| G | 2 | TEOS, DBTDL | S2 | 51 | 36.3 ± 0.3 | 452 | 0.256 |
| H | 3 | – | S2 | 64 | 48.5 ± 0.2 | 488 | 0.470 |
aCalculated as [(m 0 − m p)/m 0] × 100
bCalculated as [m d/(m 0 − m p)] × 100
where: m 0 initial mass of the blend; m p mass of precipitate; m d mass of encapsulated drug